No Detail Found!

Development of Tc-SDP-choline SPECT radiopharmaceutical for imaging of cerebrovascular diseases

Author(s)
Rashid Rasheed Department of Chemistry, Government College University,Faisalabad,Pakistan
Syed Ali Raza Naqvi Department of Chemistry, Government College University,Faisalabad,Pakistan
Rida Siraj Department of Chemistry, Government College University,Faisalabad,Pakistan
Nosheen Aslam Department of Biochemistry, Government College University,Faisalabad,Pakistan
Muhammad Waqas Nasir Department of Biochemistry, Government College University,Faisalabad,Pakistan
Ali Abbas Department of Chemistry, Government College University,Faisalabad,Pakistan
Muhammad Yaseen Department of Chemistry, University of Education (Lahore),Faisalabad Campus, Faisalabad,Pakistan
Abdul Qaddus Government College University,Faisalabad,Pakistan
Samina Roohi Pakistan Institute of Nuclear Science and Technology (PINSTECH),Nilore, Islamabad,Pakistan
Abstract
Cerebrovascular diseases are known as serious public health problem worldwide, which can be addressed more precisely through molecular imaging of non-functional brain cells. CDP-choline is an active cerebrovascular chemotherapeutic agent that can be used for diagnosis of cerebrovascular diseases post radiolabeling with ?-emitter radioisotopes. In this study we developed 99mTc labeled CDP-choline for imaging of cerebrovascular diseases particularly alzheimer, stroke, and parkinson's diseases. The radiosynthesis reaction resulted 97.47±2.34% radiochemical with promising stability, that is, >95% up to 6 h in blood serum. The biodistribution study in healthy mice revealed nonaccumulated uptake of radiochemical in key body organs; in brain it was 8.59±1.11% ID/g at 1h post-injection which washed-out leaving behind 0.87±0.61% ID/g at 24 h post-injection. The over-all data revealed the 99mTc-CDP-choline could be a good candidate for further imaging investigations in diseased animal model.
Publication Details
Page(s) 241-244
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 33, Issue: SUP1, Year: 2020

Request the full text from PASTIC

Keywords
99mTc-CDP-choline, radiopharmaceuticals, Alzheimer disease, Cerebrovascular Disease, SPECT
References
Ahmed MT,Yameen M,Munir B,Asim S,Usman M,Naqvi SAR,Gillani JAH,Rasheed R,Shahzad MA .2018 .Evaluation of 99mTc-sulfadiazine as Bacillus microorganisms infection imaging agent using animal model. Pak. J. Pharm. Sci., 31(Suppl) : 1495-1499.
Iqbal A,Naqvi SAR,Rasheed R,Mansha A,Ahmad M,Zahoor AF M .2018 .Radiosynthesis and Biodistribution of (99m)Tc-Metronidazole as an Escherichia coli Infection Imaging Radiopharmaceutical. , 185(1) : 127-139.
Iulia C,Ruxandra T,Costin LB,Liliana-Mary V .2017 .Citicoline: A neuroprotector with proven effects on glaucomatous disease. Rom. J. Ophthalmol., 61(3) : 152-158.
Khan NUH,Naqvi SAR,Roohi S,Sherazi TA,Khan ZA,Zahoor AF .2019 .Technetium-99m radiolabeling and biological study of epirubicin for in vivo imaging of multi-drug-resistant Staphylococcus aureus infections via single photon emission computed tomography. Chemical. Biology & Drug Design, 93(2) : 154-162.
Lee Z .2016 .-choline PET/CT as an imaging biomarker for primary liver cancers. Trans. Cancer Res., 5(Suppl 7) : S1489-S1492.
Nagamitsu S,Sakurai R,Matsuoka M,Chiba H,Ozono S,Tanigawa H,Yamashita Y,Kaida H,Ishibashi M,Kakuma T,Croarkin PE,Matsuishi T .2016 .Altered SPECT 123I-iomazenil binding in the cingulate cortex of children with Anorexia Nervosa. , 7 : 16.
Naqvi SA,Khan ZA,Nagra SA,Yar M,Sherazi TA,Shahzad SS,Shah SQ,Mahmood N,Ishfaq MM,Mather SJ .2013 .Novel indium-111 labeled gastrin peptide analogues (MG-CL1-4): Synthesis and quality control. Pak. J. Pharma. Sci., 26(2) : 299-305.
Naqvi SAR,Drlica K SAR .2017 .Fluoroquinolones as imaging agents for bacterial infection. Dalton. Trans, 46(42) : 14452-14460.
Naqvi SAR,Roohi S,Iqbal A,Sherazi TA,Zahoor AF,Imran M .2018 .Ciprofloxacin: from infection therapy to molecular imaging. Mol. Biol. Rep, 45(5) : 1457-1468.
Naqvi SAR,Roohi S,Sabir H,Shahzad SA,Aziz A,Rasheed R .2019 .Susceptibility of 99mTcciprofloxacin for common infection causing bacterial strains isolated from clinical samples: An in vitro and in vivo study. App, 188(1) : 424-435.
Naqvi SAR,Yameen M,Hussain Z,Asim S,Usman M,Khan N-U-H and Abbas K M .2018 .Enzymatic degradation study of 111In-labeled minigastrin peptides using cathepsin B enzyme and AR42J cancer cell line for the development of neuroendocrine tumor imaging radiopharmaceuticals. Pak. J. Pharm. Sci., 31(Suppl) : 2585-2589.
Roberti G,Tanga L,Michelessi M,Quaranta L,Parisi V,Manni G,Oddone F G,Perspectives Future .2015 .Cytidine 5'- Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence. Int J Mol Sci, 16(12) : 28401-28417.
Roberti G,Tanga L,Michelessi M,Quaranta L,Parisi V,Manni G,Oddone F G .2015 .Cytidine 5'- diphosphocholine (Citicoline) in glaucoma: rationale of its use, Current evidence and future perspectives. Inter. J. Mol. Sci, 16(12) : 28401-28417.
Sarikaya I,Sarikaya A,Elgazzar AH .2018 .Current Status of (18)F-FDG pet brain imaging in patients with dementia. J. Nucl. Med, 46(4) : 362-367.
Secades JJ,Lorenzo JL JJ .2006 .Methods and findings in experimental and clinical pharmacology 28(Suppl. , : 1-56.
0

Citations

0

Downloads

9

Views